· · · · · 

The FDA’s Hesitation to Approve ‘Female Sexual Dysfunction’ Drugs Isn’t About Sexism

The pharmaceutical industry launched a campaign in January of this year to persuade the FDA to approve such medications in the name of equality—which overlooks the fact that most of the drugs being considered simply don’t work.

The pharmaceutical industry launched a campaign in January of this year to persuade the FDA to approve such medications in the name of equality—which overlooks the fact that most of the drugs being considered simply don’t work.

· · · · · 

Morning Roundup: Price of Preterm Birth Prevention Medication Skyrockets

Preterm birth medication cost will go up 150 times due to exclusivity contract, FBI arrests suspect in Fresno Planned Parenthood arson case, Georgia moves to only allow abortions to be performed in hospitals, and Senator Rand Paul connects abortion, light bulbs, and his toilet. And he really hates his toilet.

· · · · · 

(VIDEO) A Review Of Orgasm, Inc.

A review of the film Orgasm, Inc. about the medicalization of female sexual pleasure in the US and a look into what female sexual dysfunction is and who benefits.

· · · · · 

Top Pharmaceutical Lobbyist Quits; Crafted Deal with White House on Health Reform

Billy Tauzin is resigning as president of the drug industry trade group Pharmaceutical Research and Manufacturers of America amid internal disputes over its pact with the White House to trade political support for favorable terms in health reform.

· · · · ·